Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
While opioid medications can be beneficial for pain management, in some cases they have been linked to worse outcomes and addiction.
This debate is particularly relevant to osteoarthritis – a condition that can cause persistent and often debilitating joint pain that worsens over time. Along with pain medication, surgery to replace affected joints is often a last resort.
"There exists a lot of unknowns regarding the use of opioid medication in this setting," says Krembil Clinician Investigator Dr. Raja Rampersaud.
"Few guidelines exist on the proper use of opioids for managing osteoarthritis-related pain, and recent evidence suggests that these medications are ineffective. As well, there is increasing evidence that opioid use in these patients may lead to worse surgery outcomes."
To shed more light on this issue, Dr. Rampersaud and his collaborators initiated a study to explore the effect of opioid use and other factors – such as body mass index, age, level of education and health status – on the outcomes of patients with end-stage osteoarthritis having surgery.
"After analyzing data for over 1,125 patients, we found some concerning trends," says Dr. Rampersaud.
The study revealed that a large proportion of osteoarthritis patients – up to one third – are using opioids. Furthermore, opioid use was higher in younger individuals (those under 65 years of age) and those experiencing symptoms of depression.
"Our findings provide compelling evidence that more rigorous guidelines, and effective and timely alternatives are needed to protect individuals with osteoarthritis from the potential harms of opioid use.
"Also, given that recent studies have linked opioid use to worse surgical outcomes, carefully considering patient factors, such as age and mental health, could help to counteract these effects and improve the lives of those with osteoarthritis."
This work was supported by University Health Network's Arthritis Program and the Toronto General & Western Hospital Foundation.